BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23126475)

  • 1. Duloxetine and pregabalin for pain management in multiple rheumatic diseases associated with fibromyalgia.
    Angeletti C; Guetti C; Piroli A; Angeletti PM; Paladini A; Ciccozzi A; Marinangeli F; Varrassi G
    Pain Pract; 2013 Nov; 13(8):657-62. PubMed ID: 23126475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
    Häuser W; Petzke F; Sommer C
    J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
    Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
    Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs to treat fibromyalgia - the transatlantic difference.
    Briley M
    Curr Opin Investig Drugs; 2010 Jan; 11(1):16-8. PubMed ID: 20047155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
    Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
    Pain Med; 2014 Aug; 15(8):1282-93. PubMed ID: 24401017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
    Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoteric pharmacotherapeutic targets in fibromyalgia.
    Chopra K; Kuhad A; Arora V
    Expert Opin Ther Targets; 2011 Nov; 15(11):1267-81. PubMed ID: 21905964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin: its efficacy, safety and tolerability profile in fibromyalgia syndrome.
    Owen RT
    Drugs Today (Barc); 2007 Dec; 43(12):857-63. PubMed ID: 18174971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for anticonvulsants in the management of rheumatic pain?
    Bannwarth B
    Joint Bone Spine; 2008 Dec; 75(6):633-5. PubMed ID: 18824385
    [No Abstract]   [Full Text] [Related]  

  • 13. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin for fibromyalgia: some relief but no cure.
    Kim L; Lipton S; Deodhar A
    Cleve Clin J Med; 2009 Apr; 76(4):255-61. PubMed ID: 19339642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of fibromyalgia.
    Traynor LM; Thiessen CN; Traynor AP
    Am J Health Syst Pharm; 2011 Jul; 68(14):1307-19. PubMed ID: 21719591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
    Nymdelger S; Nieber K
    Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress in the pharmacological therapy of fibromyalgia.
    Rao SG
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1479-93. PubMed ID: 19732029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibromyalgia: poorly understood; treatments are disappointing.
    Prescrire Int; 2009 Aug; 18(102):169-73. PubMed ID: 19746561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of fibromyalgia.
    Mease PJ; Dundon K; Sarzi-Puttini P
    Best Pract Res Clin Rheumatol; 2011 Apr; 25(2):285-97. PubMed ID: 22094202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.